Maravai Q4 revenue $49.9M, net loss $63M; guides 2026 revenue $200-210M

MARAVAI LIFESCIENCES HOLDINGS, INC.

2025-FY EPS reported -$0.90 revenue$185,743,000

Q4 revenue $49.9M, net loss $(63.0)M, positive Adj EBITDA $0.5M (non-GAAP).
Full year 2025 revenue $185.7M, net loss $(230.8)M, Adj EBITDA $(31.2)M.
Introduces 2026 revenue guidance $200M-$210M and Adj EBITDA guidance $18M-$20M.
CEO cites strong execution, exceeding revenue expectations, returning to positive Adj EBITDA.
Organizational restructuring and operating cost reduction ahead of plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.